Cargando…
Key person ethical decision-making and substandard drugs rejection intentions
Substandard drugs are a major public health issue worldwide. Key person such as the Qualified Person in China and Europe is responsible for rejecting substandard drugs during the manufacturing stage. This study applies the Hunt-Vitell ethical decision-making model to study their rejection intentions...
Autores principales: | Ren, Xiaohong, Wang, Xiaoyan, Sun, He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081989/ https://www.ncbi.nlm.nih.gov/pubmed/32191721 http://dx.doi.org/10.1371/journal.pone.0229412 |
Ejemplares similares
-
Factors Affecting Green Purchase Intention: A Perspective of Ethical Decision Making
por: Tian, Ziyuan, et al.
Publicado: (2022) -
Neurocircuitry of Personality Traits and Intent in Decision-Making
por: Toledo, Felippe, et al.
Publicado: (2023) -
Substandard anti-malarial drugs in Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2008) -
Substandard drugs: a potential crisis for public health
por: Johnston, Atholl, et al.
Publicado: (2014) -
ZMapp: The Ethics of Decision Making
por: Oldstone, Michael B.A., et al.
Publicado: (2017)